Jazz’ Rylaze granted expanded FDA approval for new dosing option
The expanded approval adds new dosing options for Rylaze, which provides sustained asparaginase activity for adult and paediatric…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
21 Nov 22
The expanded approval adds new dosing options for Rylaze, which provides sustained asparaginase activity for adult and paediatric…
21 Nov 22
The expanded authorisation in Canada was based on the findings of a phase 2 clinical trial held in…
18 Nov 22
TZIELD is an anti-CD3-directed antibody, indicated for administration as a once-daily intravenous infusion for 14 days, to delay…
18 Nov 22
The EC approval for Enjaymo was driven by the findings from the CADENZA and CARDINAL phase 3 clinical…
17 Nov 22
Zolbetuximab is an investigational monoclonal antibody that targets Claudin 18.2 and is used for the treatment of CLDN18.2-positive,…
17 Nov 22
The FDA advisory committee voted nine to four in favour of XPHOZAH as monotherapy and ten to two…
16 Nov 22
"Whether elevating special gatherings like holiday parties or gifting moments with family and friends, Ferrero Rocher is the…
16 Nov 22
Indivior will acquire Opiant at a price of $20 per share, for around $145m, in addition to $8…
16 Nov 22
The new Amazon Clinic will be accessible initially in 32 states and will offer virtual care for various…
16 Nov 22
Diversification of quality protein resources is essential to feed a growing population, projected to reach 10 billion by…